Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-3452.67	-967.51	-27.23
Graham Fair Price	-93.04	6.79	97.46
PEG	68240.93	-15.43	0.02
Price/Book	-26.97	1.32	1.80
Price/Cash Flow	-45.43	-31.52	-21.67
Prices/Earnings	22478.68	1549.46	-6.86
Price/Sales	54.95	11.15	7.20
Price/FCF	-45.43	-31.52	-21.67
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-90.97	0.03	-0.29
Operating Margin	72.11	-0.11	-0.38
ROA	-99.62	< 0.005	-0.03
ROE	-0.07	< 0.005	-99.68
ROIC	-0.07	< 0.005	87.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.15	0.18	-16.38
Dividends QOQ	< 0.005	< 0.005	6672.26
EBIT QOQ	-5.39	0.84	-84.42
EPS QOQ	-3.04	1.00	-66.96
FCF QOQ	-10.43	0.38	-96.31
Revenue QOQ	0.02	-0.42	2042.20
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.84	129.41	102.71
Days Sales Outstanding (DSO)	70.10	86.81	23.84
Inventory Turnover	1.41	0.70	-50.67
Debt/Capitalization	0.30	0.23	-23.94
Quick Ratio	0.77	1.64	114.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	80.20	98.19	22.43
Cash	7.58	17.50	130.83
Capex	-5.83	-4.93	15.38
Free Cash Flow	-6.67	-4.10	38.52
Revenue	20.08	11.59	-42.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.47	2.84	93.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.57	-92.92	-1932.31
Naive Interpretation	Member

06 - Financial Health · Bad

Rating